Child & Adolescent Psychiatry

Cannabis use during adolescence can profoundly impact brain development.

Finding social truth in poetic metaphors.

How can you best identify and manage pediatric PTSD?

Effective coordination of EHR system data between youth justice facilities and reentry programs can play a pivotal role in a youth’s successful reintegration into the community.

Mental health clinicians and legal practitioners can learn more about parental alienation and its treatment here.

The FDA has approved its supplemental New Drug Application for Wakix tablets for the treatment of excessive daytime sleepiness in pediatric patients aged 6 years and older with narcolepsy.

Children are subject to the world’s largest biosocial experiment.

Do physical health conditions in childhood affect ADHD symptoms at age 17 years? Researchers investigated these associations in a large cohort study.

Social media content moderation: a brief for clinicians.

Here are highlights from the week in Psychiatric Times.

“The findings emphasize the importance of monitoring the use of psychotropic combinations, particularly among vulnerable populations.”

Rikinkumar Patel, MD, MPH, shares some recent research findings with Psychiatric Times at the 2024 Annual Meeting.

Here are highlights from the first day of this year’s APA Annual Meeting.

What are the connections between cannabis use and the onset of psychotic disorders?

This 2024 APA Annual Meeting poster covered a literature review on the relationship between stimulant use and failure to thrive in pediatric patients with ADHD.

What is the potential impact of social media overuse and mental health crises in young patients?

What does the recent FDA clearance of this treatment for adolescents mean for the future of MDD treatment?

Learn more about a feasible, scalable, effective model of care that is a step away from the forced dichotomy of inpatient and outpatient care.

From a promising new intervention for treatment-resistant depression to another look at the STAR*D controversy, here are highlights from the week in Psychiatric Times.

This treatment is now the first and only TMS treatment that is FDA-cleared for this patient population.

What is new in research on COVID-19?

What is new in research on child and adolescent psychiatry?

Check out this case study to learn more about how viral infections might play a role in triggering psychotic disorders.

What is new in research on cannabis?

Here’s a look back at selections from our February content series on eating disorders.

Psychiatric Times discussed the recent research with Anne Marie O'Melia, MD, MS, FAAP, CEDS-S, of the Eating Recovery Center.

Defining threat assessment and management strategies for child and adolescent psychiatrists.

What is new in research on eating disorders?

What does recent research tell us about use of nonprescription weight-loss products among teens?

Problematic gaming is challenging to treat. Here's how you can get started.